TABLE OF CONTENTS
1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA ULTRA LOW FREEZERS MARKET 16
1.4 LIMITATIONS 18
1.5 MARKETS COVERED 18
2 MARKET SEGMENTATION 21
2.1 MARKETS COVERED 21
2.2 GEOGRAPHICAL SCOPE 22
2.3 YEARS CONSIDERED FOR THE STUDY 23
2.4 CURRENCY AND PRICING 23
2.5 DBMR TRIPOD DATA VALIDATION MODEL 24
2.6 MULTIVARIATE MODELLING 27
2.7 PRODUCT SEGMENT LIFELINE CURVE 27
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 28
2.9 DBMR MARKET POSITION GRID 29
2.10 MARKET APPLICATION COVERAGE GRID 30
2.11 VENDOR SHARE ANALYSIS 31
2.12 SECONDARY SOURCES 32
2.13 ASSUMPTIONS 32
3 EXECUTIVE SUMMARY 33
4 PREMIUM INSIGHTS 36
4.1 PESTEL ANALYSIS 37
4.2 PORTER'S 5 FORCES 38
5 REGULATORY FRAMEWORK 39
6 MARKET OVERVIEW 41
6.1 DRIVERS 43
6.1.1 INCREASING DEMAND FOR BIOPHARMACEUTICALS AND VACCINES 43
6.1.2 RISING DEMAND FOR BLOOD AND BLOOD COMPONENTS 43
6.1.3 TECHNICAL ADVANCEMENTS IN ULTRA LOW FREEZER DESIGN 45
6.1.4 RISING R&D ACTIVITIES IN LIFE SCIENCES 46
6.2 RESTRAINTS 47
6.2.1 HIGH INSTALLATION AND OPERATIONAL COST OF ULTRA LOW FREEZERS 47
6.2.2 ENVIRONMENTAL CONCERNS ASSOCIATED WITH ULTRA LOW FREEZERS 48
6.3 OPPORTUNITIES 49
6.3.1 INCREASING DEMAND FOR BIOPRESERVATION AND BIOBANKING 49
6.3.2 INCREASING RESEARCH IN REGENERATIVE MEDICINE 50
6.4 CHALLENGES 51
6.4.1 TEMPERATURE VALIDATION AND CALIBRATION OF ULTRA LOW FREEZERS 51
6.4.2 DIFFICULTY IN MAINTENANCE AND REPAIRS OF ULTRA LOW FREEZERS 52
7 MIDDLE EAST AND AFRICA ULTRA LOW FREEZERS MARKET, BY TYPE 53
7.1 OVERVIEW 54
7.2 PRODUCT 57
7.2.1 UPRIGHT ULTRA LOW TEMPERATURE FREEZER 57
7.2.2 CHEST ULTRA LOW TEMPERATURE FREEZER 57
7.2.3 BENCHTOP/UNDERCOUNTER ULTRA LOW TEMPERATURE FREEZER 58
7.2.4 OTHERS 58
7.3 FREEZER PARTS AND ACCESSORIES 58
8 MIDDLE EAST AND AFRICA ULTRA LOW FREEZERS MARKET, BY TECHNOLOGY 59
8.1 OVERVIEW 60
8.2 AUTOMATED FREEZERS 63
8.3 SEMI-AUTOMATED FREEZERS 63
9 MIDDLE EAST AND AFRICA ULTRA LOW FREEZERS MARKET, BY DEGREE OF COOLING 64
9.1 OVERVIEW 65
9.2 -41C TO -86 C FREEZERS 68
9.3 -87C TO -150 C FREEZERS 68
9.4 -10C TO -40 C FREEZERS 68
10 MIDDLE EAST AND AFRICA ULTRA LOW FREEZERS MARKET, BY INSULATED MATERIAL 70
10.1 OVERVIEW 71
10.2 POLYURETHANE FOAM 74
10.3 VACUUM PANELS 74
10.4 OTHERS 74
11 MIDDLE EAST AND AFRICA ULTRA LOW FREEZERS MARKET, BY APPLICATION 76
11.1 OVERVIEW 77
11.2 BLOOD & BLOOD PRODUCTS 80
11.3 BIOLOGICAL SAMPLES 80
11.4 DRUG COMPOUNDS 81
11.5 ORGANS 81
11.6 OTHERS 82
12 MIDDLE EAST AND AFRICA ULTRA LOW FREEZERS MARKET, BY END USER 83
12.1 OVERVIEW 84
12.2 HOSPITALS 87
12.2.1 LONG-TERM CARE HOSPITALS 87
12.2.2 ACUTE CARE HOSPITALS 87
12.2.3 NURSING FACILITIES 87
12.2.4 REHABILITATION CENTERS 88
12.3 CORPORATE LABORATORIES 88
12.4 PHARMACEUTICALS COMPANIES 88
12.5 BIO-BANKS 89
12.6 CLINICS 89
12.7 ACADEMIC AND RESEARCH INSTITUTES 90
12.8 OTHERS 90
13 MIDDLE EAST AND AFRICA ULTRA LOW FREEZERS MARKET, BY DISTRIBUTION CHANNEL 91
13.1 OVERVIEW 92
13.2 DIRECT TENDERS 95
13.3 RETAIL SALES 95
13.4 THIRD PARTY DISTRIBUTORS 96
14 MIDDLE EAST AND AFRICA ULTRA LOW FREEZER MARKET, BY REGION 97
14.1 MIDDLE EAST AND AFRICA 97
14.1.1 SAUDI ARABIA 101
14.1.2 SOUTH AFRICA 104
14.1.3 U.A.E. 107
14.1.4 EGYPT 111
14.1.5 ISRAEL 114
14.1.6 REST OF MIDDLE EAST 117
15 MIDDLE EAST AND AFRICA ULTRA LOW FREEZERS MARKET, COMPANY LANDSCAPE 119
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA 119
16 SWOT ANALYSIS 120
17 COMPANY PROFILE 121
17.1 PHC CORPORATION 121
17.1.1 COMPANY SNAPSHOT 121
17.1.2 REVENUE ANALYSIS 121
17.1.3 COMPANY SHARE ANALYSIS 122
17.1.4 PRODUCT PORTFOLIO 122
17.1.5 RECENT DEVELOPMENT 122
17.2 EPPENDORF SE 123
17.2.1 COMPANY SNAPSHOT 123
17.2.2 COMPANY SHARE ANALYSIS 123
17.2.3 PRODUCT PORTFOLIO 124
17.2.4 RECENT DEVELOPMENT 124
17.3 THERMO FISHER SCIENTIFIC INC. 125
17.3.1 COMPANY SNAPSHOT 125
17.3.2 REVENUE ANALYSIS 125
17.3.3 COMPANY SHARE ANALYSIS 126
17.3.4 PRODUCT PORTFOLIO 126
17.3.5 RECENT DEVELOPMENT 126
17.4 VWR INTERNATIONAL, LLC. 127
17.4.1 COMPANY SNAPSHOT 127
17.4.2 COMPANY SHARE ANALYSIS 127
17.4.3 PRODUCT PORTFOLIO 128
17.4.4 RECENT DEVELOPMENT 128
17.5 BIOLIFE SOLUTIONS INC. 129
17.5.1 COMPANY SNAPSHOT 129
17.5.2 REVENUE ANALYSIS 129
17.5.3 COMPANY SHARE ANALYSIS 130
17.5.4 PRODUCT PORTFOLIO 130
17.5.5 RECENT DEVELOPMENTS 130
17.6 ARCTIKO 131
17.6.1 COMPANY SNAPSHOT 131
17.6.2 PRODUCT PORTFOLIO 131
17.6.3 RECENT DEVELOPMENT 131
17.7 ATICOEXPORT 132
17.7.1 COMPANY SNAPSHOT 132
17.7.2 PRODUCT PORTFOLIO 132
17.7.3 RECENT DEVELOPMENT 132
17.8 B MEDICAL SYSTEMS 133
17.8.1 COMPANY SNAPSHOT 133
17.8.2 PRODUCT PORTFOLIO 133
17.8.3 RECENT DEVELOPMENT 133
17.9 BINDER GMBH 134
17.9.1 COMPANY SNAPSHOT 134
17.9.2 PRODUCT PORTFOLIO 134
17.9.3 RECENT DEVELOPMENT 134
17.10 BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD. 135
17.10.1 COMPANY SNAPSHOT 135
17.10.2 PRODUCT PORTFOLIO 135
17.10.3 RECENT DEVELOPMENT 135
17.11 BIOWAY CORPORATION 136
17.11.1 COMPANY SNAPSHOT 136
17.11.2 PRODUCT PORTFOLIO 136
17.11.3 RECENT DEVELOPMENT 136
17.12 ESCO MICRO PTE. LTD. 137
17.12.1 COMPANY SNAPSHOT 137
17.12.2 PRODUCT PORTFOLIO 137
17.12.3 RECENT DEVELOPMENT 137
17.13 EVERMED S.R.L. 138
17.13.1 COMPANY SNAPSHOT 138
17.13.2 PRODUCT PORTFOLIO 138
17.13.3 RECENT DEVELOPMENT 138
17.14 FUKUSHIMA GALILEI CO. LTD. 139
17.14.1 COMPANY SNAPSHOT 139
17.14.2 REVENUE ANALYSIS 139
17.14.3 PRODUCT PORTFOLIO 140
17.14.4 RECENT DEVELOPMENT 140
17.15 HELMER SCIENTIFIC INC. 141
17.15.1 COMPANY SNAPSHOT 141
17.15.2 PRODUCT PORTFOLIO 141
17.15.3 RECENT DEVELOPMENTS 142
17.16 LABCOLD 143
17.16.1 COMPANY SNAPSHOT 143
17.16.2 PRODUCT PORTFOLIO 143
17.16.3 RECENT DEVELOPMENT 143
17.17 NUAIRE, INC. 144
17.17.1 COMPANY SNAPSHOT 144
17.17.2 PRODUCT PORTFOLIO 144
17.17.3 RECENT DEVELOPMENT 145
17.18 REMI GROUP. 146
17.18.1 COMPANY SNAPSHOT 146
17.18.2 REVENUE ANALYSIS 146
17.18.3 PRODUCT PORTFOLIO 147
17.18.4 RECENT DEVELOPMENT 147
17.19 TELSTAR 148
17.19.1 COMPANY SNAPSHOT 148
17.19.2 PRODUCT PORTFOLIO 148
17.19.3 RECENT DEVELOPMENT 148
17.20 VESTFROST SOLUTIONS 149
17.20.1 COMPANY SNAPSHOT 149
17.20.2 PRODUCT PORTFOLIO 149
17.20.3 RECENT DEVELOPMENT 149
18 QUESTIONNAIRE 150
19 RELATED REPORTS 153

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.